ClinicalTrials.gg
CompletedNCT07740915Updated Oct 13, 2026

Comparison of Erector Spinae Plane Block and Modified Pectoral Fascial Plane Block for Postoperative Analgesia in Pediatric Cardiac Surgery

An interventional study of Ultrasound-Guided Erector Spinae Plane Block and Ultrasound-Guided Modified Pectoral Fascial Plane Block in Congenital Heart Disease, Postoperative Pain After Cardiac Surgery Via Median Sternotomy and Anesthesia, sponsored by Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 0 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital · Not applicable, Interventional, and Treatment

How we know

Updated Oct 13, 2026Now CompletedStart date moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
0 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 32 studies in Heart Defects, Congenital with a site in Turkey — 11 open to participants now, 12 under way, none of them phase 3. Heart Defects, Congenital · Turkey.

Enrollment
10th of 18
50 · median 51
Started
2026
with 4 others
No phase
17 of 32
8 open now
Registered
30th of 32
by date

Among the 32 studies in Heart Defects, Congenital with a site in Turkey, this one is the 10th largest by enrollment of the 18 interventional ones that give a count, is one of 5 that started in 2026, is one of 17 with no phase, and was the 30th registered.

Heart Defects, Congenital

992 studies on the registry are indexed under Heart Defects, Congenital; 252 are open to participants now.

Browse Heart Defects, Congenital studies →

Open to participants now

11 of the 32 studies in Heart Defects, Congenital with a site in Turkey are open now. Recruiting first, the newest first:

6 more — sign in →

All 11 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 156 Heart Defects, Congenital studies recruiting now, 69 (44%) set no upper age limit and 79 (51%) stop at 75 or younger; 112 take children under 18; 25 take healthy volunteers.

This study: 0 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 32 studies in Heart Defects, Congenital with a site in Turkey, or all of them as a file.
02

Study summary

Postoperative pain management is an essential component of perioperative care in pediatric congenital cardiac surgery. Regional anesthesia techniques, including the erector spinae plane block (ESPB) and modified pectoral fascial plane block (M-PFPB), are increasingly used as part of multimodal analgesia; however, evidence directly comparing these techniques in pediatric cardiac surgery remains limited.

This prospective randomized controlled study aims to compare the analgesic efficacy of ESPB and M-PFPB in pediatric patients undergoing elective congenital cardiac surgery. The primary objective is to identify the regional anesthesia technique associated with more effective postoperative pain control. Secondary objectives include comparison of perioperative opioid consumption, hemodynamic parameters, extubation time, postoperative pain scores, perioperative complications, and intensive care unit and hospital length of stay. The findings are expected to contribute to the optimization of perioperative analgesia protocols and improve postoperative recovery in pediatric cardiac surgery.

Read the detailed description

Effective postoperative analgesia is a key determinant of recovery following pediatric congenital cardiac surgery. Adequate pain control may reduce opioid requirements, facilitate early extubation, decrease perioperative complications, and improve overall postoperative outcomes. Among the regional anesthesia techniques used in pediatric cardiac surgery, erector spinae plane block (ESPB) and modified pectoral fascial plane block (M-PFPB) have gained increasing attention because of their potential to provide effective analgesia while minimizing opioid exposure.

This prospective randomized controlled trial is designed to compare the analgesic efficacy of ESPB and M-PFPB in pediatric patients undergoing first-time elective congenital cardiac surgery. Patients younger than 18 years who meet the eligibility criteria will be enrolled after written informed consent has been obtained from their parents or legal guardians.

Demographic characteristics, including age, sex, body mass index, ASA physical status, and cardiac diagnosis, will be recorded. Perioperative variables, including cardiopulmonary bypass duration, aortic cross-clamp time, duration of surgery, duration of anesthesia, intraoperative and postoperative opioid consumption, intraoperative hemodynamic parameters (heart rate, blood pressure, near-infrared spectroscopy, and oxygen saturation), extubation time, postoperative FLACC pain scores, perioperative complications, intensive care unit length of stay, and hospital length of stay, will be prospectively collected and analyzed.

The primary objective of the study is to determine which regional anesthesia technique provides more effective postoperative analgesia in pediatric congenital cardiac surgery. Secondary objectives include comparison of opioid requirements, postoperative recovery parameters, and perioperative complications between the two study groups. The study findings are expected to support the development of evidence-based perioperative analgesia protocols for pediatric cardiac surgery and contribute to the current literature.

03

Conditions studied

  • Congenital Heart Disease
  • Postoperative Pain After Cardiac Surgery Via Median Sternotomy
  • Anesthesia
04

Who can participate

Ages eligible
0 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients younger than 18 years of age.
  • Scheduled for first-time elective congenital cardiac surgery.
  • Written obtained from a parent or legal guardian.

Exclusion criteria

Exclusion Criteria:

  • Redo cardiac surgery.
  • Emergency surgery.
  • to regional fascial plane block (e.g., infection at the injection site or allergy to local anesthetics).
  • Coagulopathy.
  • Chronic liver disease.
  • Renal failure.
  • History of opioid use before surgery.
  • Failure to obtain written from a parent or legal guardian.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
50 participants (actual)

Study arms

  • Active comparator
    Erector Spinae Plane Block

    Participants randomized to this group will receive an ultrasound-guided erector spinae plane block (ESPB) as part of multimodal perioperative analgesia before elective congenital cardiac surgery. Standard perioperative anesthesia and postoperative analgesia protocols will be applied to all participants

    Procedure: Ultrasound-Guided Erector Spinae Plane Block

  • Active comparator
    Modified Pectoral Fascial Plane Block

    Participants randomized to this group will receive an ultrasound-guided modified pectoral fascial plane block (M-PFPB) as part of multimodal perioperative analgesia before elective congenital cardiac surgery. Standard perioperative anesthesia and postoperative analgesia protocols will be applied to all participants.

    Procedure: Ultrasound-Guided Modified Pectoral Fascial Plane Block

Interventions

  • ProcedureUltrasound-Guided Erector Spinae Plane Block

    Ultrasound-guided erector spinae plane block will be performed bilaterally after induction of general anesthesia and before surgical incision to provide postoperative analgesia in pediatric patients undergoing congenital cardiac surgery.

  • ProcedureUltrasound-Guided Modified Pectoral Fascial Plane Block

    Ultrasound-guided modified pectoral fascial plane block will be performed bilaterally after induction of general anesthesia and before surgical incision to provide postoperative analgesia in pediatric patients undergoing congenital cardiac surgery.

06

What researchers measure

Primary outcomes

  1. Total Postoperative Opioid Consumption

    Total opioid consumption during the first 24 hours after surgery will be recorded and compared between the Erector Spinae Plane Block (ESPB) and Modified Pectoral Fascial Plane Block (M-PFPB) groups.

    Time frame: 24 hours postoperatively

Secondary outcomes

  1. Time to Extubation

    The time from the end of surgery until successful tracheal extubation will be recorded.

    Time frame: From the end of surgery up to 48 hours postoperatively

  2. Postoperative FLACC Pain Scores

    Postoperative pain intensity will be assessed using the Face, Legs, Activity, Cry, and Consolability (FLACC) pain assessment scale. FLACC scores will be recorded prospectively and compared between the Erector Spinae Plane Block (ESPB) and Modified Pectoral Fascial Plane Block (M-PFPB) groups

    Time frame: Assessed at 0, 1, 2, 4, 8, 12, 18, and 24 hours postoperatively

07

Study locations

1 site
  • SBU Gazi Yasargil TRH
    Diyarbakır, Diyarbakır 210070, Turkey (Türkiye)
08

References and documents

Publications

  • Kumar AK, Chauhan S, Bhoi D, Kaushal B. Pectointercostal Fascial Block (PIFB) as a Novel Technique for Postoperative Pain Management in Patients Undergoing Cardiac Surgery. J Cardiothorac Vasc Anesth. 2021 Jan;35(1):116-122. doi: 10.1053/j.jvca.2020.07.074. Epub 2020 Jul 30. PubMed 32859487 ↗
  • Kaushal B, Chauhan S, Magoon R, Krishna NS, Saini K, Bhoi D, Bisoi AK. Efficacy of Bilateral Erector Spinae Plane Block in Management of Acute Postoperative Surgical Pain After Pediatric Cardiac Surgeries Through a Midline Sternotomy. J Cardiothorac Vasc Anesth. 2020 Apr;34(4):981-986. doi: 10.1053/j.jvca.2019.08.009. Epub 2019 Aug 12. PubMed 31515190 ↗
  • Macaire P, Ho N, Nguyen V, Phan Van H, Dinh Nguyen Thien K, Bringuier S, Capdevila X. Bilateral ultrasound-guided thoracic erector spinae plane blocks using a programmed intermittent bolus improve opioid-sparing postoperative analgesia in pediatric patients after open cardiac surgery: a randomized, double-blind, placebo-controlled trial. Reg Anesth Pain Med. 2020 Oct;45(10):805-812. doi: 10.1136/rapm-2020-101496. Epub 2020 Aug 19. PubMed 32817407 ↗

Individual participant data

Plan to share: Yes

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2026 to primary completion in Oct 2026, 2 months.

Of 208 non-industry interventional studies with no phase under Heart Defects, Congenital, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's 2 months is below that.

Counting every sponsor, half of 226 studies reached it within 34 months; a quarter within 17 and three quarters within 57.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 13, 2026: start Jun 2026 → Jul 2026, primary completion Aug 2026 → Oct 2026 and completion Aug 2026 → Oct 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 27, 2026
First posted
Aug 3, 2026
StartActual
Jul 30, 2026was Jun 2026
Primary completionActual
Oct 5, 2026was Aug 2026
CompletionActual
Oct 10, 2026was Aug 2026
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Enrolling by invitation→Completed
changed Oct 13, 2026
Start date
Jun 30, 2026→Jul 30, 2026
Oct 13, 2026
Primary completion
Aug 15, 2026→Oct 5, 2026 (actual)
Oct 13, 2026
Study completion
Aug 30, 2026→Oct 10, 2026 (actual)
Oct 13, 2026
Enrollment
40 (estimated)→50 (actual)
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    Enrolling by invitation→Completed
    Start date Jun 30, 2026→Jul 30, 2026
    Primary completion Aug 15, 2026→Oct 5, 2026 (now actual)
    Study completion Aug 30, 2026→Oct 10, 2026 (now actual)
    Enrollment 40 (estimated)→50 (actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07740915
Lead sponsor
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Responsible party
Mustafa Bıçak (Associated proffessor, Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital) — Principal investigator
First posted
Aug 3, 2026
Start date
Jul 30, 2026
Primary completion
Oct 5, 2026
Completion
Oct 10, 2026
Last update
Oct 13, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion